While Pharmaceutical and Biopharma stocks have been taking a beating in 2018/19 medical device makers are on a roll , they are in one of the hottest trends in the market, seemingly bullet proof from they bears. NYSE:EW is on a perfect trend for 2 years and as earnings approach on the 23rd July it looks like a real good bet to move higher.
Indicators are all...
Its always good to brush up on our trading rules. One rule I live by is that past resistance acts as future support, in case you couldn't tell by the chart! In late June the price was met with resistance at $154. After retracing and testing support again, the stock is ready to try again. If the price does bust above previous resistance @$154 I'd expect a move up...
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
EW
